Fremont, United States
APstem Therapeutics is pioneering an innovative approach in the biotechnology and healthcare sectors with its breakthrough discovery of Adult Pluripotent Stem Cells (APSCs™). Founded in 2017 and based in the United States, the company aims to tackle difficult-to-heal diseases and address aging-related challenges.
Their mission-driven proposition is heralded by the slogan, "An unprecedented era of stem cell therapy has arrived!" This encapsulates their commitment to advancing life sciences through transformative stem cell therapies. In pursuit of this mission, APstem Therapeutics secured a $2.80M Seed Round investment on 01 September 2020 from notable investors such as Beyond Ventures, Oriza Ventures, and Magic Capital.
As a promising player in these high-impact industries, the company presents a compelling opportunity for investors keen on innovative therapeutic solutions targeting unmet medical needs.
